From 1 April, Japan’s Ministry of Health, Labour and Welfare will implement its next wide-ranging revision of drug prices. They are set to bring down the average reimbursement price under the national health insurance system by an average of 6.69%. (Also see "Too Fast, Too Much? Japan Cuts Prices By 6.7% As Annual Revisions Bite" - Pink Sheet, 30 March, 2022.)
Generic drugs for which the market share exceeded 80% for the last two years will receive hefty price cuts